From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy
By
Zhiwei Xu
Shi Bai
Caidi He
Xiaobei Lv
Qin Li
Qile Mao
Haijian Wu
Peter Wang
May 13, 2026
Clinical Scorecard: Identifying Risk Factors and Molecular Targets: Clinical Links and Molecular Docking Analysis of Phthalate-Related Diabetic Retinopathy
At a Glance
Category Detail
Condition Diabetic Retinopathy (DR) Key Mechanisms Phthalate exposure, AGE-RAGE signaling, apoptosis-related pathways Target Population Adults with diabetes Care Setting Clinical and epidemiological settings
Key Highlights
Longer weekday outdoor time increases DR odds (OR = 3.18) Higher serum vitamin D levels decrease DR odds (OR = 0.80) Cataract strongly associated with DR (OR = 11.0) Less electronic device use correlates with lower DR odds (OR = 0.67) Phthalate exposure linked to DR through urinary biomarkers Guideline-Based Recommendations
Diagnosis
Routine screening for early detection of DR is essential. Management
Address modifiable risk factors such as lifestyle behaviors. Monitoring & Follow-up
Regular assessment of serum vitamin D and phthalate exposure. Risks
Increased risk of DR associated with hypertension, elevated HbA1c, and environmental exposures. Patient & Prescribing Data
Diabetic patients, particularly those with lifestyle risk factors
Consider environmental exposures and lifestyle modifications in DR management.
Clinical Best Practices
Encourage physical activity and a balanced diet to reduce DR risk. Monitor and manage blood glucose levels and hypertension. Educate patients on the potential risks of phthalate exposure. Related Resources & Content
